Healthcare of patients with atopic dermatitis by general practitioners - a nationwide survey in Germany.

IF 5.5 4区医学 Q1 DERMATOLOGY Journal Der Deutschen Dermatologischen Gesellschaft Pub Date : 2024-09-03 DOI:10.1111/ddg.15529

Anna Langenbruch, Valerie Andrees, Martin Scherer, Matthias Augustin

{"title":"Healthcare of patients with atopic dermatitis by general practitioners - a nationwide survey in Germany.","authors":"Anna Langenbruch, Valerie Andrees, Martin Scherer, Matthias Augustin","doi":"10.1111/ddg.15529","DOIUrl":null,"url":null,"abstract":"Background and objectives: Epidemiological studies on the health care of patients with atopic dermatitis (AD) in dermatological treatment in Germany indicate no improvements within 10 years. In addition to dermatologists, general practitioners (GPs) are particularly involved in AD treatment. This study analyzed the health care situation of adult patients with AD by GPs.Patients and methods: The cross-sectional questionnaire survey \"PsoADA\" was conducted from 2019 to 2021 in general practices throughout Germany and the results were compared with previous data from dermatology care (AtopicHealth2, 2017-19).Results: Among 150 patients (mean age: 40 years, 62.2% female), 39.2% received additional treatment by a dermatologist (GP+D). 20.7% of GP+D and 5.7% of patients in GP treatment only (GP only) had severe AD (p < 0.01, AtopicHealth2: 27.6%). Major limitations in quality of life were reported by 31.0% (GP+D) versus 3.4% (GP only) (p < 0.001, AtopicHealth2: 31.6%). Most patients received topicals, mainly glucocorticosteroids. Calcineurin inhibitors were currently administered by 2.7% (PsoADA total). Patient education was reported by 5.7% (PsoADA total).Conclusions: A considerable proportion of patients with AD in GP care shows poor outcomes, as has been observed in dermatological care - possibly due to the lack of use of modern systemic therapy.","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":null,"pages":null},"PeriodicalIF":5.5000,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal Der Deutschen Dermatologischen Gesellschaft","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ddg.15529","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background and objectives: Epidemiological studies on the health care of patients with atopic dermatitis (AD) in dermatological treatment in Germany indicate no improvements within 10 years. In addition to dermatologists, general practitioners (GPs) are particularly involved in AD treatment. This study analyzed the health care situation of adult patients with AD by GPs.

Patients and methods: The cross-sectional questionnaire survey "PsoADA" was conducted from 2019 to 2021 in general practices throughout Germany and the results were compared with previous data from dermatology care (AtopicHealth2, 2017-19).

Results: Among 150 patients (mean age: 40 years, 62.2% female), 39.2% received additional treatment by a dermatologist (GP+D). 20.7% of GP+D and 5.7% of patients in GP treatment only (GP only) had severe AD (p < 0.01, AtopicHealth2: 27.6%). Major limitations in quality of life were reported by 31.0% (GP+D) versus 3.4% (GP only) (p < 0.001, AtopicHealth2: 31.6%). Most patients received topicals, mainly glucocorticosteroids. Calcineurin inhibitors were currently administered by 2.7% (PsoADA total). Patient education was reported by 5.7% (PsoADA total).

Conclusions: A considerable proportion of patients with AD in GP care shows poor outcomes, as has been observed in dermatological care - possibly due to the lack of use of modern systemic therapy.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

全科医生对特应性皮炎患者的医疗保健--德国全国调查。

背景和目的：对德国特应性皮炎（AD）患者在皮肤病治疗方面的保健情况进行的流行病学研究表明，10 年内情况没有任何改善。除皮肤科医生外，全科医生（GPs）也特别参与特应性皮炎的治疗。本研究分析了全科医生对成人过敏性皮炎患者的医疗保健情况：2019年至2021年，在德国各地的全科医生中开展了横断面问卷调查 "PsoADA"，并将调查结果与之前的皮肤病护理数据（AtopicHealth2，2017-19年）进行了比较：在150名患者（平均年龄：40岁，62.2%为女性）中，39.2%接受了皮肤科医生（GP+D）的额外治疗。20.7%的GP+D患者和5.7%的仅接受GP治疗的患者患有严重的注意力缺失症（P 结论：在接受GP+D治疗的患者中，有相当一部分患有严重的注意力缺失症：相当一部分接受全科医生治疗的 AD 患者疗效不佳，皮肤科治疗也是如此，这可能是由于缺乏使用现代系统疗法的缘故。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal Der Deutschen Dermatologischen Gesellschaft 医学-皮肤病学

CiteScore

3.50

自引率

25.00%

发文量

406

审稿时长

1 months

期刊介绍： The JDDG publishes scientific papers from a wide range of disciplines, such as dermatovenereology, allergology, phlebology, dermatosurgery, dermatooncology, and dermatohistopathology. Also in JDDG: information on medical training, continuing education, a calendar of events, book reviews and society announcements. Papers can be submitted in German or English language. In the print version, all articles are published in German. In the online version, all key articles are published in English.